ZEB1 downregulation in B16-F10 melanoma cells and in its presumed cancer-stem cell CD133+ CD44+ subpopulation reduced their tumor growth in vivo, yet it has not been shown whether lack of ZEB1 effectively depletes the CD133+ CD44+ fraction in B16-F10 tumors as such (10). This evidence concerns the gene ZEB1 and neoplasm.